Copy number loss of ARG2 and ASS1 genes are high in ccRCC patients (38% and 24%, respectively) and their combined loss connotes a nearly 3-year reduction in overall survival. This evidence concerns the gene ARG2 and nonpapillary renal cell carcinoma.